Life sciences

#Drug discovery #Infectious diseases #Life sciences #Research

Millions invested to help life sciences fight infectious disease

The UK’s centre for therapeutics innovation, Medicines Discovery Catapult (MDC), has received a £5 million grant to build a Translational Research Facility in Infectious Disease on its Alderley Park site, as part of the government’s Getting Building Fund programme. Actively seeking collaborations with SMEs, academics and others in infectious disease… Read More

#News

#Drug development #Drug discovery #ELRIG #Events #Life sciences

Weather the Storm: Drug Discovery and the ELRIG community

On May 27, 2021, ELRIG’s “hot topic” webinar, Weathering the Storm: Drug Discovery & the ELRIG Community takes place virtually. Scientists, medical professionals, business leaders and others associated with the life sciences, which ELRIG consider to be the core of their drug discovery community, and who, throughout the pandemic, have… Read More

#News

#Bioentrepreneur #Digital focus #Life sciences

Life science co-working space aims to empower bioentrepreneurs

HelaPlex is working with Scispot to create a digital life science accelerator. The collaboration will allow HelaPlex to offer a secure digital space to its members and enable them to manage research, resources, and partners in one spot, as per commercial regulatory requirements. “I believe the bio revolution is on… Read More

#News

#Assay #Bioscience #Data #Drug discovery #Drug targets #Interview #Life sciences #Screening

Ask the expert: assisting researchers with hit-to-lead

Pelago Bioscience is a specialised CRO, focusing on its patented Cellular Thermal Shift Assay (CETSA), which can assess therapeutically relevant target engagement in cells or tissue of unmodified compounds against the native, full-length proteins of interest. Stina Lundgren, Principal Project Advisor, shared the company’s hit-to-lead expertise with Lu Rahman. CETSA… Read More

#Editor's Choice #Exclusive Content #News

#Cell and gene therapy #Drug delivery #Drug development #Drug innovation #Life sciences

RoslinCT selected as vaccines and advanced therapies training centre

RoslinCT has been confirmed as a National Training Centre, part of the Department for Business, Energy & Industrial Strategy (BEIS) sponsored Advanced Therapies Skills Training Network (ATSTN) initiative. The organisation is the second National Training Centre confirmed as part of the ATSTN initiative, which was set up to develop vaccine… Read More

#News

#Biopharmaceutical #Covid-19 #Life sciences #Pharmaceutical research #Vaccines

ABPI chief stresses importance of research investment

The Chief Executive of the UK’s Association of the British Pharmaceutical Industry (ABPI), Richard Torbett, has stressed the importance of investment in research in response to the Queen’s Speech delivery. “The response to the pandemic has shown just how critical the UK’s pharmaceutical industry is to our country’s future and… Read More

#News #Trending News

#Biologics / Biotechnology #Cell sequencing #DNA #Drug development #Drug discovery #Genome editing #Genome sequencing #Life sciences #Sequencing #Synthetic biology

The new synthesis: How synthetic DNA technology is changing drug discovery

Listen to this article on the DDW Podcast: Dr Tim Brears, CEO, Evonetix and Dr Raquel Sanches-Kuiper, Director of Biology, Evonetix explore applications of synthetic DNA in drug discovery and development, the benefits and limitations of current methods, and the opportunities offered by emerging DNA synthesis technologies. On 16 April 16,… Read More

#Editor's Choice #Exclusive Content #News #Opinion

#Bioban #Biologics #Covid-19 #Life sciences #Thermo Fisher Scientific

Reforming biobanks: from siloes to collaborative powerhouses

By Erik Steinfelder, Biobanking Market Development Director at Thermo Fisher Scientific From hidden repositories, secreted deep in the basements of universities and hospitals, to the emergence of collaborative powerhouses driving ground-breaking therapies, biobanks have come a long way in the past 30 years. Biobanks were originally created as vast repositories… Read More

#Covid-19 #Exclusive Content #News

#Biopharmaceuticals #Drug development #Life sciences

Awakn Life Sciences and Evotec start chemical entity programme

Awakn Life Sciences, a biotechnology company focused on addiction, has initiated a new chemical entity (NCE) development programme to strengthen its pipeline for the treatment of a broad range of addictions. The company has also announced the appointment of Evotec as its NCE research partner and the selection of… Read More

#News

#Events #Life sciences

SLAS Europe 2021 will be online only

The SLAS Europe 2021 Conference & Exhibition has announced it will be in an online format only. The event will include current research and collaboration, including more than 25 scientific talks across three educational tracks, 12 vendor tutorials and three keynotes, with added flexibility and opportunity to either watch content… Read More

#News

#Corning Life Sciences #Drug delivery #Drug development #Drug discovery #Gene therapy #Genetics #Genetics / genomes #Life sciences #Research

Process Development in Gene Therapy: Four Things to Know

By John Yoshi Shyu, Ph.D. Corning Life Sciences. Gene therapy – the addition, deletion, or modification of genes in living organisms – has been around, at least in concept, since the 1980s. Gene modification or editing incorporates two main strategies: insertion of novel genetic constructs into existing genes, and gene… Read More

#Exclusive Content #News

#Assay development optimisation & technology #Cell and protein analysis #Drug development #Drug discovery #Life sciences

PerkinElmer supports consortium aimed at advancing PROTAC drugs

PerkinElmer is serving as a provider and co-developer of assays, instrument solutions and expertise for the PROXIDRUGS Consortium which is zeroing in on research for proximity drugs or PROTACs (PROteolysis Targeting Chimeras). PROTACs are a new class of drugs that take advantage of the body’s own cell protein recycling system… Read More

#News

#AI / data analytics / healthtech / informatics #Augmented reality #Covid-19 #Life sciences #Virtual reality

Virtual and augmented reality – expanding data insights

Insights from data hold the key to understanding how effectively companies are operating and to making connections that lead to discovery and innovation. Recently, software solutions have got better at providing graphical dashboards that help decision-makers visualise their data. In the near future, virtual or augmented reality (VR/AR) technology will… Read More

#Editor's Choice #Exclusive Content #News #Regulatory

#Biopharmaceuticals #Biotechnology #Life sciences

New initiative focusses on Lab To Leadership in drug discovery

Clearworks Coaching is offering a Lab To Leadership initiative that aims to assist leadership development, helping scientists reach their leadership potential early in their career. Clearworks Coaching has been developing UK senior leaders since 2005 and specialises in STEM, biotech and pharma. The organisation has recognised that the gap between… Read More

#News

#Biopharmaceuticals #Data #Drug development #Life sciences

Price control could cut medicine development by 88% in California

Researchers from Biocom California and the California Life Sciences Association (CLSA) have released data analysing the potential impact of international reference pricing (foreign price controls) on California’s biopharmaceutical innovation ecosystem, including investment into small company capital formation and the new drug development pipeline. The analysis shows that implementing foreign reference… Read More

#News

#Biopharma #Biotechnology #Covid-19 #Drug discovery #Laboratory data #Life sciences

From siloed to streamlined: Pharma data management is changing

Claire Hill, Head of Strategic Marketing at IDBS, explores ways in which the pharmaceutical sector can reap the benefits of an increasingly digital world. The Covid-19 pandemic pushed the process of drug development into the spotlight in a new way. The challenge for biopharmaceutical companies—to create, test, and manufacture a… Read More

#Exclusive Content #News #Opinion